Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2011

Feb 9, 2011

32853_dirs_2011-02-09_786d929b-1135-45ce-a279-0bf32b886eeb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2011-02-09

Reporting Person: COLELLA SAMUEL D (Director)

Holdings (Non-Derivative)

Security Shares Ownership
Series E1 Preferred Stock 164 Indirect
Series E1 Preferred Stock 346 Indirect
Series E1 Preferred Stock 148 Indirect
Series E1 Preferred Stock 7596 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Series E Preferred Warrant (Right to Buy) $24.22 Common Stock (479) Indirect
Series E Preferred Stock $0 Common Stock (2065) Indirect
Series B Preferred Stock $0 Common Stock (7297) Indirect
Series C Preferred Stock $0 Common Stock (6401) Indirect
Series D Preferred Stock $0 Common Stock (1769) Indirect
Series E Preferred Warrant (Right to Buy) $24.22 Common Stock (1417) Indirect
Series E Preferred Stock $0 Common Stock (5185) Indirect
Series B Preferred Stock $0 Common Stock (29190) Indirect
Series C Preferred Stock $0 Common Stock (13442) Indirect
Series D Preferred Stock $0 Common Stock (3715) Indirect
Series E Preferred Warrant (Right to Buy) $24.22 Common Stock (544) Indirect
Series E Preferred Stock $0 Common Stock (2092) Indirect
Series B Preferred Stock $0 Common Stock (10425) Indirect
Series C Preferred Stock $0 Common Stock (5760) Indirect
Series D Preferred Stock $0 Common Stock (1592) Indirect
Series E Preferred Warrant (Right to Buy) $24.22 Common Stock (26181) Indirect
Series E Preferred Stock $0 Common Stock (103546) Indirect
Series B Preferred Stock $0 Common Stock (474354) Indirect
Series C Preferred Stock $0 Common Stock (294457) Indirect
Series D Preferred Stock $0 Common Stock (81396) Indirect
Stock Option (Right to Buy) $8.38 Common Stock (8670) Direct
Stock Option (Right to Buy) $4.45 Common Stock (8670) Direct
Series E1 Preferred Warrant (Right to Buy) $0.02 Common Stock (8257) Indirect

Footnotes

F1: Reflects a 1-for-1.73 reverse stock split of the Issuer's outstanding shares effected February 3, 2011.

F2: Versant Affiliates Fund 1-A, L.P., is the record holder of the securities reported on Lines 1, 2, 3, 4, 5 and 6 of Table 2.

F3: Voting and investment power over the shares directly held by Versant Venture Capital I, L.P., Versant Affiliates Fund I-A, L.P., Versant Affiliates Fund I-B, L.P., and Versant Side Fund I, L.P. is held by Versant Ventures I, LLC, their sole General Partner. Samuel D. Colella, the reporting person is a Managing Member of Versant Ventures I, LLC but he disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The individual Managing Members of Versant Ventures I, LLC are Brian G. Atwood, Samuel D. Colella, Ross A. Jaffe, William J. Link, Barbara N. Lubash, Donald B. Milder, and Rebecca B. Robertson, all of whom share voting and dispositive control. Each respective individual General Partner disclaims beneficial ownership of these shares, except to the extent of their pecuniary interest therein.

F4: Versant Affiliates Fund 1-B, L.P., is the record holder of the securities.

F5: Versant Side Fund 1, L.P., is the record holder of the securities.

F6: Versant Venture Capital I, L.P., is the record holder of the securities.

F7: Reflects the automatic conversion of each share of Series E Preferred Stock into 1.3 shares of Common Stock to occur upon the closing of the Issuer's initial public offering.

F8: Expires immediately prior to the closing of the Issuer's initial public offering.

F9: Reflects the automatic conversion of each share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E1 Preferred Stock into one share of Common Stock to occur upon the closing of the Issuer's initial public offering. Each share has no expiration date.

F10: Each share has no expiration date.

F11: 1/12th of the shares subject to such Option shall vest on each monthly anniversary of January 28, 2011 (the "Vesting Commencement Date"), such that the Option will be fully vested on the first annual anniversary of the Vesting Commencement Date. The Option shall expire on January 6, 2021.

F12: The Option fully vested on January 28, 2011. The Option shall expire on January 28, 2020.

F13: The Colella Family Trust U/D/T dated September 21, 1992 is the record holder of the securites reported on line 27 of Table 2. Samuel D. Colella and Nancy R. Colella are trustees of the Colella Family Trust U/D/T dated September 21, 1992.